824 related articles for article (PubMed ID: 28352155)
1. Proteinopathy, oxidative stress and mitochondrial dysfunction: cross talk in Alzheimer's disease and Parkinson's disease.
Ganguly G; Chakrabarti S; Chatterjee U; Saso L
Drug Des Devel Ther; 2017; 11():797-810. PubMed ID: 28352155
[TBL] [Abstract][Full Text] [Related]
2. Role of protein aggregation in mitochondrial dysfunction and neurodegeneration in Alzheimer's and Parkinson's diseases.
Hashimoto M; Rockenstein E; Crews L; Masliah E
Neuromolecular Med; 2003; 4(1-2):21-36. PubMed ID: 14528050
[TBL] [Abstract][Full Text] [Related]
3. Oxidative Stress in Neurodegenerative Diseases: From a Mitochondrial Point of View.
Cenini G; Lloret A; Cascella R
Oxid Med Cell Longev; 2019; 2019():2105607. PubMed ID: 31210837
[TBL] [Abstract][Full Text] [Related]
4. Mitochondrial dysfunction and oxidative stress in Alzheimer's disease, and Parkinson's disease, Huntington's disease and Amyotrophic Lateral Sclerosis -An updated review.
Alqahtani T; Deore SL; Kide AA; Shende BA; Sharma R; Dadarao Chakole R; Nemade LS; Kishor Kale N; Borah S; Shrikant Deokar S; Behera A; Dhawal Bhandari D; Gaikwad N; Kalam Azad A; Ghosh A
Mitochondrion; 2023 Jul; 71():83-92. PubMed ID: 37269968
[TBL] [Abstract][Full Text] [Related]
5. Mitochondrial dysfunction and oxidative damage in Alzheimer's and Parkinson's diseases and coenzyme Q10 as a potential treatment.
Beal MF
J Bioenerg Biomembr; 2004 Aug; 36(4):381-6. PubMed ID: 15377876
[TBL] [Abstract][Full Text] [Related]
6. The Role of Mitochondria in Neurodegenerative Diseases: the Lesson from Alzheimer's Disease and Parkinson's Disease.
Monzio Compagnoni G; Di Fonzo A; Corti S; Comi GP; Bresolin N; Masliah E
Mol Neurobiol; 2020 Jul; 57(7):2959-2980. PubMed ID: 32445085
[TBL] [Abstract][Full Text] [Related]
7. Role of zinc and copper ions in the pathogenetic mechanisms of Alzheimer's and Parkinson's diseases.
Stelmashook EV; Isaev NK; Genrikhs EE; Amelkina GA; Khaspekov LG; Skrebitsky VG; Illarioshkin SN
Biochemistry (Mosc); 2014 May; 79(5):391-6. PubMed ID: 24954589
[TBL] [Abstract][Full Text] [Related]
8. Oxidative stress: A major pathogenesis and potential therapeutic target of antioxidative agents in Parkinson's disease and Alzheimer's disease.
Jiang T; Sun Q; Chen S
Prog Neurobiol; 2016 Dec; 147():1-19. PubMed ID: 27769868
[TBL] [Abstract][Full Text] [Related]
9. Emerging pathways to neurodegeneration: Dissecting the critical molecular mechanisms in Alzheimer's disease, Parkinson's disease.
Tan SH; Karri V; Tay NWR; Chang KH; Ah HY; Ng PQ; Ho HS; Keh HW; Candasamy M
Biomed Pharmacother; 2019 Mar; 111():765-777. PubMed ID: 30612001
[TBL] [Abstract][Full Text] [Related]
10. Non-Amyloid-β Component of Human α-Synuclein Oligomers Induces Formation of New Aβ Oligomers: Insight into the Mechanisms That Link Parkinson's and Alzheimer's Diseases.
Atsmon-Raz Y; Miller Y
ACS Chem Neurosci; 2016 Jan; 7(1):46-55. PubMed ID: 26479553
[TBL] [Abstract][Full Text] [Related]
11. [Free radical processes in aging, neurodegenerative diseases and other pathological states].
Dubinina EE; Pustygina AV
Biomed Khim; 2007; 53(4):351-72. PubMed ID: 18035718
[TBL] [Abstract][Full Text] [Related]
12. Glycation in Parkinson's disease and Alzheimer's disease.
Vicente Miranda H; El-Agnaf OM; Outeiro TF
Mov Disord; 2016 Jun; 31(6):782-90. PubMed ID: 26946341
[TBL] [Abstract][Full Text] [Related]
13. The Role of Reactive Oxygen Species in the Pathogenesis of Alzheimer's Disease, Parkinson's Disease, and Huntington's Disease: A Mini Review.
Manoharan S; Guillemin GJ; Abiramasundari RS; Essa MM; Akbar M; Akbar MD
Oxid Med Cell Longev; 2016; 2016():8590578. PubMed ID: 28116038
[TBL] [Abstract][Full Text] [Related]
14. alpha-synuclein aggregation: a link between mitochondrial defects and Parkinson's disease?
Lee SJ
Antioxid Redox Signal; 2003 Jun; 5(3):337-48. PubMed ID: 12880487
[TBL] [Abstract][Full Text] [Related]
15. Structure of amyloid oligomers and their mechanisms of toxicities: Targeting amyloid oligomers using novel therapeutic approaches.
Salahuddin P; Fatima MT; Abdelhameed AS; Nusrat S; Khan RH
Eur J Med Chem; 2016 May; 114():41-58. PubMed ID: 26974374
[TBL] [Abstract][Full Text] [Related]
16. Neuronal response in Alzheimer's and Parkinson's disease: the effect of toxic proteins on intracellular pathways.
Majd S; Power JH; Grantham HJ
BMC Neurosci; 2015 Oct; 16():69. PubMed ID: 26499115
[TBL] [Abstract][Full Text] [Related]
17. Mitochondrial and Ubiquitin Proteasome System Dysfunction in Ageing and Disease: Two Sides of the Same Coin?
Ross JM; Olson L; Coppotelli G
Int J Mol Sci; 2015 Aug; 16(8):19458-76. PubMed ID: 26287188
[TBL] [Abstract][Full Text] [Related]
18. Interplay between MicroRNAs and Oxidative Stress in Neurodegenerative Diseases.
Konovalova J; Gerasymchuk D; Parkkinen I; Chmielarz P; Domanskyi A
Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31801298
[TBL] [Abstract][Full Text] [Related]
19. Mitochondria as a pharmacological target: magnum overview.
Olszewska A; Szewczyk A
IUBMB Life; 2013 Mar; 65(3):273-81. PubMed ID: 23441041
[TBL] [Abstract][Full Text] [Related]
20. Mitochondria are a direct site of A beta accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression.
Manczak M; Anekonda TS; Henson E; Park BS; Quinn J; Reddy PH
Hum Mol Genet; 2006 May; 15(9):1437-49. PubMed ID: 16551656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
